1.
7 walnuts a day deliver health benefits
PARIS, May 14 (UPI) -- Nautilus said Monday the U.S. Food and Drug Administration cleared its potential hepatitis C treatment, oral Belerofon, for a phase 1 trial.
Belerofon is a formulation of interferon-alpha that is intended to last longer in serum and reach blood levels comparable to those obtained by injected products.
"The development of an orally administered Interferon-alpha highlights the potential of Nautilus Biotech's technology platform," said Paul Martin, the firm's vice president of strategy. "It represents the promise of a third generation of therapeutic protein drugs that can be taken more easily and have great commercial potential to replace established injectable products."
The phase 1 trial of Belerofon is scheduled to begin later this year. Nautilus said it will be an open-label, ascending dose study of four doses of the investigational compound.
|
|
|
|
|
|
| Additional Health News Stories | |
DETROIT, Feb. 14 (UPI) --
The Nigerian who tried to blow up a Detroit-bound jetliner on Christmas Day 2009 shouldn't receive life in prison for the failed attack, his legal adviser said.
|
HOLLYWOOD, Feb. 14 (UPI) --
Hollywood's Paramount Pictures says director Michael Bay is to helm a fourth Transformers movie to be released in 2014.
|
CORPUS CHRISTI, Texas, Feb. 14 (UPI) --
Texas police said they arrested an 18-year-old woman who led them on a chase while wearing nothing but a pair of cowboy boots.
|
BAGHDAD, Feb. 14 (UPI) --
U.S. supermajor Exxon Mobil won't be able to take part in an oil and natural gas licensing auction scheduled for May in Iraq, a spokesman said.
|
| Stories | Photos | People | Comments |
View Caption
